Annual Accounts Payable
$22.79 M
-$4.43 M-16.27%
31 December 2023
Summary:
REGENXBIO annual accounts payable is currently $22.79 million, with the most recent change of -$4.43 million (-16.27%) on 31 December 2023. During the last 3 years, it has risen by +$12.16 million (+114.52%). RGNX annual accounts payable is now -16.27% below its all-time high of $27.21 million, reached on 31 December 2022.RGNX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$19.52 M
+$3.16 M+19.31%
30 September 2024
Summary:
REGENXBIO quarterly accounts payable is currently $19.52 million, with the most recent change of +$3.16 million (+19.31%) on 30 September 2024. Over the past year, it has dropped by -$2.34 million (-10.69%). RGNX quarterly accounts payable is now -37.74% below its all-time high of $31.36 million, reached on 31 March 2024.RGNX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.3% | -10.7% |
| 3 y3 years | +114.5% | -1.6% |
| 5 y5 years | +416.5% | +103.2% |
RGNX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.3% | +114.5% | -37.7% | +71.4% |
| 5 y | 5 years | -16.3% | +416.5% | -37.7% | +204.6% |
| alltime | all time | -16.3% | +7470.1% | -37.7% | +5744.9% |
REGENXBIO Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.52 M(+19.3%) |
| June 2024 | - | $16.36 M(-47.8%) |
| Mar 2024 | - | $31.36 M(+37.6%) |
| Dec 2023 | $22.79 M(-16.3%) | $22.79 M(+4.2%) |
| Sept 2023 | - | $21.86 M(+87.8%) |
| June 2023 | - | $11.64 M(-50.0%) |
| Mar 2023 | - | $23.28 M(-14.4%) |
| Dec 2022 | $27.21 M(+139.0%) | $27.21 M(+7.9%) |
| Sept 2022 | - | $25.21 M(+48.4%) |
| June 2022 | - | $16.98 M(-31.3%) |
| Mar 2022 | - | $24.71 M(+117.0%) |
| Dec 2021 | $11.39 M(+7.2%) | $11.39 M(-42.6%) |
| Sept 2021 | - | $19.84 M(+112.2%) |
| June 2021 | - | $9.35 M(-17.3%) |
| Mar 2021 | - | $11.31 M(+6.5%) |
| Dec 2020 | $10.62 M(+65.7%) | $10.62 M(-30.3%) |
| Sept 2020 | - | $15.24 M(+39.8%) |
| June 2020 | - | $10.90 M(+21.0%) |
| Mar 2020 | - | $9.01 M(+40.6%) |
| Dec 2019 | $6.41 M | $6.41 M(-33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $9.61 M(+64.2%) |
| June 2019 | - | $5.85 M(+39.2%) |
| Mar 2019 | - | $4.20 M(-4.7%) |
| Dec 2018 | $4.41 M(-8.7%) | $4.41 M(-15.4%) |
| Sept 2018 | - | $5.21 M(+23.3%) |
| June 2018 | - | $4.23 M(-15.5%) |
| Mar 2018 | - | $5.01 M(+3.6%) |
| Dec 2017 | $4.83 M(+213.2%) | $4.83 M(+86.3%) |
| Sept 2017 | - | $2.59 M(-34.3%) |
| June 2017 | - | $3.95 M(-4.4%) |
| Mar 2017 | - | $4.13 M(+167.6%) |
| Dec 2016 | $1.54 M(+52.2%) | $1.54 M(-71.3%) |
| Sept 2016 | - | $5.38 M(+159.0%) |
| June 2016 | - | $2.08 M(+86.5%) |
| Mar 2016 | - | $1.11 M(+9.8%) |
| Dec 2015 | $1.01 M(+203.6%) | $1.01 M(-67.3%) |
| Sept 2015 | - | $3.10 M(+235.7%) |
| June 2015 | - | $925.00 K(+176.9%) |
| Dec 2014 | $334.00 K(+11.0%) | $334.00 K |
| Dec 2013 | $301.00 K | - |
FAQ
- What is REGENXBIO annual accounts payable?
- What is the all time high annual accounts payable for REGENXBIO?
- What is REGENXBIO annual accounts payable year-on-year change?
- What is REGENXBIO quarterly accounts payable?
- What is the all time high quarterly accounts payable for REGENXBIO?
- What is REGENXBIO quarterly accounts payable year-on-year change?
What is REGENXBIO annual accounts payable?
The current annual accounts payable of RGNX is $22.79 M
What is the all time high annual accounts payable for REGENXBIO?
REGENXBIO all-time high annual accounts payable is $27.21 M
What is REGENXBIO annual accounts payable year-on-year change?
Over the past year, RGNX annual accounts payable has changed by -$4.43 M (-16.27%)
What is REGENXBIO quarterly accounts payable?
The current quarterly accounts payable of RGNX is $19.52 M
What is the all time high quarterly accounts payable for REGENXBIO?
REGENXBIO all-time high quarterly accounts payable is $31.36 M
What is REGENXBIO quarterly accounts payable year-on-year change?
Over the past year, RGNX quarterly accounts payable has changed by -$2.34 M (-10.69%)